Transverse Myelitis
40 Transverse Myelitis Isabella Strozzi and Michael Levy KEY POINTS FOR CLINICIANS • Incidence of acute transverse myelitis (TM) is reported at 1.34 to 4.6 new cases per million annually. It…
Pain Management in Multiple Sclerosis
25 Pain Management in Multiple Sclerosis John F. Foley, Ryan R. Metzger, Kara Menning, Cortnee Roman, and Emily N. Stuart KEY POINTS FOR CLINICIANS • Pain is a common symptom…
Tools and Tests for Multiple Sclerosis
9 Tools and Tests for Multiple Sclerosis Robert A. Bermel KEY POINTS FOR CLINICIANS • Blood tests play an important role in excluding mimics of multiple sclerosis (MS). • Spinal fluid analysis…
Upper Extremity Function in Multiple Sclerosis
26 Upper Extremity Function in Multiple Sclerosis Christine Smith and Kathleen M. Zackowski KEY POINTS FOR CLINICIANS • Upper extremity (UE) dysfunction is a common issue for individuals with multiple sclerosis…
Treating Progressive Multiple Sclerosis
15 Treating Progressive Multiple Sclerosis Carrie M. Hersh KEY POINTS FOR CLINICIANS • Primary progressive multiple sclerosis (PPMS) is defined by progressive accrual of disability in the absence of relapses. • Secondary…
Neurosarcoidosis
42 Neurosarcoidosis Brandon P. Moss and Jinny Tavee KEY POINTS FOR THE CLINICIAN • Neurologic complications are seen in 5% to 10% of patients with systemic sarcoidosis, but are the presenting…
Neuromyelitis Optica
PART VI. RELATED DISEASES 38 Neuromyelitis Optica Amanda L. Piquet and John R. Corboy KEY POINTS FOR THE CLINICIAN • Neuromyelitis optica (NMO) is a distinct clinical–pathological disease that is…
Treating Relapsing Forms of Multiple Sclerosis: Infusion Therapies
14 Treating Relapsing Forms of Multiple Sclerosis: Infusion Therapies Jenny J. Feng and Daniel Ontaneda KEY POINTS FOR CLINICIANS • There are six infusion therapies for the treatment of relapsing forms…
Cognitive Dysfunction in Multiple Sclerosis
21 Cognitive Dysfunction in Multiple Sclerosis Stephen M. Rao KEY POINTS FOR CLINICIANS Cognitive dysfunction … • Occurs in 43% to 65% of patients with multiple sclerosis (MS) • Is often under…
Emerging Therapies
16 Emerging Therapies Michael D. Kornberg and Peter A. Calabresi KEY POINTS FOR CLINICIANS • Current disease-modifying therapies target the peripheral immune system with a primary goal of preventing relapses. • The…
